By contrast, our study showed that GDF15 has anti-inflammatory and anti-fibrotic roles in CCl4-induced chronic (3 week) liver fibrosis, which is more generally used to induce liver fibrosis than a single CCl4 injection. Here, GDF15 is linked to Hepatic fibrosis.